PURPOSE: The goal of our study was to determine whether genomic copy number abnormalities (deletions and duplications) affecting genes involved in eye development contributed to the etiology of anophthalmia, microphthalmia, and coloboma. METHODS: The affected individuals were evaluated for the presence of deletions and duplications in genomic DNA by a very high-resolution array comparative genomic hybridization. RESULTS: Array analysis of 32 patients detected one case with a deletion encompassing the renal-coloboma syndrome associated gene PAX2. Nonpolymorphic copy number changes were also observed at several candidate chromosomal regions, including 6p12.3, 8q23.1q23.2, 13q31.3, 15q11.2q13.1, 16p13.13, and 20q13.13. CONCLUSIONS: This study identified the first patient with the typical phenotype of the renal-coloboma syndrome caused by a submicroscopic deletion of the coding region of the PAX2 gene. The finding suggests that PAX2 deletion testing should be performed in addition to gene sequencing as a part of molecular evaluation for the renal-coloboma syndrome. Array comparative genomic hybridization testing of 32 affected individuals showed that genomic deletions and duplications are not a common cause of nonsyndromic anophthalmia, microphthalmia, or coloboma but undoubtedly contribute to the etiology of these eye anomalies. Therefore, array comparative genomic hybridization testing represents an important and valuable addition to candidate gene sequencing in research and diagnostics of ocular birth defects.
PURPOSE: The goal of our study was to determine whether genomic copy number abnormalities (deletions and duplications) affecting genes involved in eye development contributed to the etiology of anophthalmia, microphthalmia, and coloboma. METHODS: The affected individuals were evaluated for the presence of deletions and duplications in genomic DNA by a very high-resolution array comparative genomic hybridization. RESULTS: Array analysis of 32 patients detected one case with a deletion encompassing the renal-coloboma syndrome associated gene PAX2. Nonpolymorphic copy number changes were also observed at several candidate chromosomal regions, including 6p12.3, 8q23.1q23.2, 13q31.3, 15q11.2q13.1, 16p13.13, and 20q13.13. CONCLUSIONS: This study identified the first patient with the typical phenotype of the renal-coloboma syndrome caused by a submicroscopic deletion of the coding region of the PAX2 gene. The finding suggests that PAX2 deletion testing should be performed in addition to gene sequencing as a part of molecular evaluation for the renal-coloboma syndrome. Array comparative genomic hybridization testing of 32 affected individuals showed that genomic deletions and duplications are not a common cause of nonsyndromic anophthalmia, microphthalmia, or coloboma but undoubtedly contribute to the etiology of these eye anomalies. Therefore, array comparative genomic hybridization testing represents an important and valuable addition to candidate gene sequencing in research and diagnostics of ocular birth defects.
Authors: Lisenka E L M Vissers; Conny M A van Ravenswaaij; Ronald Admiraal; Jane A Hurst; Bert B A de Vries; Irene M Janssen; Walter A van der Vliet; Erik H L P G Huys; Pieter J de Jong; Ben C J Hamel; Eric F P M Schoenmakers; Han G Brunner; Joris A Veltman; Ad Geurts van Kessel Journal: Nat Genet Date: 2004-08-08 Impact factor: 38.330
Authors: C E Browne; N R Dennis; E Maher; F L Long; J C Nicholson; J Sillibourne; J C Barber Journal: Am J Hum Genet Date: 1997-12 Impact factor: 11.025
Authors: Ryan Chao; Linda Nevin; Pooja Agarwal; Jan Riemer; Xiaoyang Bai; Allen Delaney; Matthew Akana; Nelson JimenezLopez; Tanya Bardakjian; Adele Schneider; Nicolas Chassaing; Daniel F Schorderet; David FitzPatrick; Pui-yan Kwok; Lars Ellgaard; Douglas B Gould; Yan Zhang; Jarema Malicki; Herwig Baier; Anne Slavotinek Journal: PLoS One Date: 2010-05-11 Impact factor: 3.240
Authors: Ana Belinda Campos-Xavier; Danielle Martinet; John Bateman; Dan Belluoccio; Lynn Rowley; Tiong Yang Tan; Alica Baxová; Karl-Henrik Gustavson; Zvi U Borochowitz; A Micheil Innes; Sheila Unger; Jacques S Beckmann; Lauréane Mittaz; Diana Ballhausen; Andrea Superti-Furga; Ravi Savarirayan; Luisa Bonafé Journal: Am J Hum Genet Date: 2009-05-28 Impact factor: 11.025
Authors: Klara Flipsen-ten Berg; Peter M van Hasselt; Marc J Eleveld; Suzanne E van der Wijst; Frans A Hol; Monique A M de Vroede; Frits A Beemer; P F Ron Hochstenbach; Martin Poot Journal: Eur J Hum Genet Date: 2007-07-18 Impact factor: 4.246
Authors: A M Slavotinek; S T Garcia; G Chandratillake; T Bardakjian; E Ullah; D Wu; K Umeda; R Lao; P L-F Tang; E Wan; L Madireddy; S Lyalina; B A Mendelsohn; S Dugan; J Tirch; R Tischler; J Harris; M J Clark; S Chervitz; A Patwardhan; J M West; P Ursell; A de Alba Campomanes; A Schneider; P-Y Kwok; S Baranzini; R O Chen Journal: Clin Genet Date: 2015-01-06 Impact factor: 4.438
Authors: K F Schilter; L M Reis; A Schneider; T M Bardakjian; O Abdul-Rahman; B A Kozel; H H Zimmerman; U Broeckel; E V Semina Journal: Clin Genet Date: 2013-06-17 Impact factor: 4.438
Authors: Mani Yahyavi; Hana Abouzeid; Ghada Gawdat; Anne-Sophie de Preux; Tong Xiao; Tanya Bardakjian; Adele Schneider; Alex Choi; Eric Jorgenson; Herwig Baier; Mohamad El Sada; Daniel F Schorderet; Anne M Slavotinek Journal: Hum Mol Genet Date: 2013-04-15 Impact factor: 6.150
Authors: Fiona Blanco-Kelly; María Palomares; Elena Vallespín; Cristina Villaverde; Rubén Martín-Arenas; Camilo Vélez-Monsalve; Isabel Lorda-Sánchez; Julián Nevado; María José Trujillo-Tiebas; Pablo Lapunzina; Carmen Ayuso; Marta Corton Journal: PLoS One Date: 2017-02-23 Impact factor: 3.240